Resistance-Associated Gene Variants Found In Hep C Patients Who Received First

Resistance-Associated Gene Variants Found In Hep C Patients Who Received First … First-generation triple therapies for hepatitis C virus (HCV) infection are being phased out in favor of next-generation interferon-free direct-acting antiviral agents (DAAs). When the old drugs are no … Continue reading

AbbVie gets FDA approval for Hepatitis C combination therapy

AbbVie gets FDA approval for Hepatitis C combination therapy Daklinza plus sofosbuvir resulted in 90% SVR12 in treatment-naive and 86% in treatment-experienced chronic HCV genotype 3 patients. Most people infected with HCV have no symptoms of the disease until liver … Continue reading